• Corpus ID: 42973786

Effectiveness of probiotic therapy against diarrhoea Diarrhoea Probiotic strain Outcome of treatment

  title={Effectiveness of probiotic therapy against diarrhoea Diarrhoea Probiotic strain Outcome of treatment},
  author={Kieran Michael Tuohy and Hollie M. Probert and Christopher Smejkal and G. R. Gibson},
A complex community of microorganisms inhabit the gastrointestinal tract throughout its length. The colon is the main site of microbial colonization and, typically, the indigenous microbiota are considered to be made up of more than 500 different species of bacteria. Recent molecular studies have confirmed this view of microbial diversity within the gut [1]. The gut microbiota plays an important role in both human health and disease [2]. The main function of the gut microbiota, from the host’s… 

Figures and Tables from this paper


Probiotics as modulators of the gut flora
The approach of modulating the gut flora for improved health has much relevance for the management of those with acute and chronic gut disorders, as well as the elderly, who have an altered microflora, with a decreased number of beneficial microbial species.
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.
By combining the rationale of pro- and prebiotics, the concept of synbiotics is proposed to characterize some colonic foods with interesting nutritional properties that make these compounds candidates for classification as health-enhancing functional food ingredients.
Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics
Dietary intervention of the human gut microbiota is feasible and has been proven as efficacious in volunteer trials, and the health bonuses of such approaches offer the potential to manage many gut disorders prophylactically.
Probiotics: effects on immunity.
The data show that probiotics can be used as innovative tools to alleviate intestinal inflammation, normalize gut mucosal dysfunction, and down-regulate hypersensitivity reactions and suggest that specific immunomodulatory properties of probiotic bacteria should be characterized when developing clinical applications for extended target populations.
Probiotics and inflammatory bowel disease: is there a scientific rationale?
  • F. Shanahan
  • Medicine, Biology
    Inflammatory bowel diseases
  • 2000
The circumstantial evidence for some form of biotherapeutic modification of the enteric flora in Crohn's disease seems compelling and probiotics may offer a simple adjunct to conventional therapy with the emphasis on diet shifting from one of nutritional replenishment alone to a more functional role.
Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998.
Consumption of foods containing Lactobacillus GG may shorten the course of rotavirus infection and well-designed placebo-controlled studies with validated outcome variables are needed to determine the health effects of probiotic bacteria.
Probiotics and intestinal health effects: a clinical perspective
The evidence for the efficacy of specific probiotic strains in human gastrointestinal diseases is critically analysed and the recent randomised controlled trials performed in patients with Clostridium difficile or Helicobacter pylori, inflammatory bowel disease, irritable bowel syndrome, non-ulcer dyspepsia and colon cancer are analysed.
Prebiotics and probiotics: are they functional foods?
  • M. Roberfroid
  • Biology
    The American journal of clinical nutrition
  • 2000
Claims about reduction of disease risk are only tentative and further research is needed, but several health-related effects associated with the intake of probiotics, including alleviation of lactose intolerance and immune enhancement, have been reported in human studies.
Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?
  • H. Malchow
  • Medicine, Biology
    Journal of clinical gastroenterology
  • 1997
Part of the intestinal microflora, including the host's immune response toward indigenous flora or an impairment of the gut flora's metabolic activity are involved in the development or at least in the onset of relapse from remissive of colonic Crohn's disease, are convinced.
Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression.
The hypothesis is that the ability of probiotic agents to inhibit adherence of attaching and effacing organisms to intestinal epithelial cells is mediated through their ability to increase expression of MUC2 and MUC3 intestinal mucins.